Patent · US Active

Amatoxin-antibody conjugates

US10842882B2 · kind B2 · utility

3Cited by

0References

9Claims

0Family size

Assignee

Heidelberg Pharma GmbH · DE

Inventors

Jan Anderl · Herchenrode, DE
Torsten Hechler · Ladenburg, DE
Christoph Müller · Birkenau, DE
Andreas Pahl · Ladenburg, DE

Key dates

Filing date	Mar 7, 2016
Grant date	Nov 24, 2020
Priority date	—
Expiry date	Jul 4, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/55
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to conjugates comprising amatoxins and antibodies, in particular amatoxins linked to antibodies comprising specific cysteine residues.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.